🇺🇸 FDA
Patent

US 7531556

Compositions useful as inhibitors of rock and other protein kinases

granted A61PA61P1/04A61P11/06

Quick answer

US patent 7531556 (Compositions useful as inhibitors of rock and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P1/04, A61P11/06, A61P15/06, A61P15/10